SAT-LB031 Empagliflozin as an Add-On Medication to Subjects Uncontrolled on DPP4 Inhibitors and Metformin: Real World Data Supporting the Use of Empagliflozin as a Rational Second Add-On in Indian Type 2 Diabetic Patients
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
pp. 123
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 11
(6)
◽
pp. 992-1000
◽
Keyword(s):
Keyword(s):